Denitsa Milanova

President at Marble Therapeutics, Inc.

39 year

Consumer Services

Commercial Services

Profile

Denitsa M.
Milanova is an Independent Non-Executive Director at InSilico Medicine Cayman TopCo and holds the positions of President, Treasurer, Director & Vice President at Marble Therapeutics, Inc. She received her doctorate degree from Stanford University in 2016 and her undergraduate degree from the University of Central Florida in 2008.

Denitsa Milanova active positions

Companies	Position	Start
Insilico Medicine Cayman TopCo Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong.	Director/Board Member	2023-05-31
Marble Therapeutics, Inc. Marble Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Marble Therapeutics, Inc. develops gene therapies. The company is based in Boston, MA.	President	-

All active positions of Denitsa Milanova

Training of Denitsa Milanova

Stanford University	Doctorate Degree
University of Central Florida	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Denitsa Milanova's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Insilico Medicine Cayman TopCo Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong.	Commercial Services
Marble Therapeutics, Inc. Marble Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Marble Therapeutics, Inc. develops gene therapies. The company is based in Boston, MA.	Commercial Services